BackKura Oncology Overview

Kura Oncology Selling, General & Admin

Selling, General & Admin expenses for KURA.

Quarterly SG&A Expenses

$31.20M
↑ 36.63% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$128.35M
↑ 56.98% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin